Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

<h4>Aims</h4>The advent of direct-acting antivirals for hepatitis C virus (HCV) and limited effectiveness of prevention have generated interest in "Treatment as Prevention" (TasP), in which those most likely to transmit HCV (i.e. people who inject drugs [PWID]) are treated to r...

Full description

Bibliographic Details
Main Authors: Phillip O Coffin, Glenn-Milo Santos, Emily Behar, Jaclyn Hern, John Walker, Tim Matheson, Elizabeth N Kinnard, Janelle Silvis, Eric Vittinghoff, Rena Fox, Kimberley Page
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217471

Internet

https://doi.org/10.1371/journal.pone.0217471

Similar Items